Document is current
Any future updates will be listed below
-
Authors
Paparini, Sara https://orcid.org/0000-0002-1909-2481
Hayes, Rosalie https://orcid.org/0000-0003-4046-4101
Weil, Benjamin
Nutland, Will
Maatouk, Ismael https://orcid.org/0000-0003-1008-7413
Wi, Teodora https://orcid.org/0000-0002-7640-9166
Orkin, Chloe M. https://orcid.org/0000-0001-6168-6745
Lewis, Rosamund https://orcid.org/0000-0002-7227-2545
- License Information
-
More Information
Article History
Received: 18 July 2024
Accepted: 19 December 2024
First Online: 21 January 2025
Declarations
:
: Ethics approval for the study was obtained from the Queen Mary Ethics of Research Committee on 20 December 2023 (QMERC23.045). All participants received a participant information sheet and gave written and verbal informed consent to take part in the study.
: Not applicable.
: CMO has received honoraria for advisory boards, lectureships and travel sponsorships from Janssen, Gilead Sciences, ViiV Healthcare, MSD and Bavarian Nordic and has received research grants from Janssen, Gilead Sciences, ViiV Healthcare, MSD and AstraZeneca. SP has received research grants from Gilead Sciences and ViiV Healthcare. The remaining authors (RH, BW, WN, IM, TW and RL) declare that they have no competing interests.
